Skip to Content

Events

Events List

News

Discontinuation of COVID-Era Practice Regarding Waitlist Screening Parameters

Apr 6, 2026, 14:55 PM by Anna Shults

From the Organ Procurement and Transplantation Network (OPTN), April 3, 2026

The Organ Procurement and Transplantation Network (OPTN), in collaboration with the Health Resources and Services Administration (HRSA), is notifying members that prior COVID-era guidance permitting the use of certain waitlist screening parameters to prevent organ offers is rescinded, effective immediately.

In April 2020, during the COVID-19 emergency, the OPTN issued guidance permitting transplant programs to temporarily implement waitlist screening criteria. This approach enabled candidates to keep accumulating waiting time even if they were not eligible to receive organ offers at that moment. These criteria included setting donor age limits to a minimum of 98 years and a maximum of 99 years.

The COVID-19 public health emergency has ended. Moving forward, transplant programs must return to using the OPTN-approved procedures to temporarily inactivate candidates. This is critical to ensure patient safety and system integrity. It is inappropriate to continue to use excessively narrow donor acceptance criteria or other screening parameters to effectively render a candidate ineligible for organ offers.

Required Member Actions

  • Transplant programs must discontinue the use of donor age acceptance criteria (e.g., 98-99 years) or other screening parameters intended to functionally inactivate candidates.
  • Programs must use established inactive status procedures when a candidate is temporarily unable to accept organ offers.
  • Listing parameters must reflect clinically appropriate ranges and must not be used to prevent organ offers.

OPTN Monitoring Going Forward

The OPTN will regularly review waitlist parameter data to identify potentially ineffective listing practices. The OPTN may contact programs it identifies as having extreme or implausible acceptance ranges and ask them to review and, if necessary, correct those listings.

The OPTN reserves the right to issue further guidance or formal policies based on its review of waitlist parameter data.

The OPTN appreciates your prompt attention to this matter and your continued commitment to maintaining a safe, fair, and reliable organ donation, procurement, and transplantation system.

View the Full Announcement

Discontinuation of COVID-Era Practice Regarding Waitlist Screening Parameters

Apr 6, 2026, 14:55 PM by Anna Shults

From the Organ Procurement and Transplantation Network (OPTN), April 3, 2026

The Organ Procurement and Transplantation Network (OPTN), in collaboration with the Health Resources and Services Administration (HRSA), is notifying members that prior COVID-era guidance permitting the use of certain waitlist screening parameters to prevent organ offers is rescinded, effective immediately.

In April 2020, during the COVID-19 emergency, the OPTN issued guidance permitting transplant programs to temporarily implement waitlist screening criteria. This approach enabled candidates to keep accumulating waiting time even if they were not eligible to receive organ offers at that moment. These criteria included setting donor age limits to a minimum of 98 years and a maximum of 99 years.

The COVID-19 public health emergency has ended. Moving forward, transplant programs must return to using the OPTN-approved procedures to temporarily inactivate candidates. This is critical to ensure patient safety and system integrity. It is inappropriate to continue to use excessively narrow donor acceptance criteria or other screening parameters to effectively render a candidate ineligible for organ offers.

Required Member Actions

  • Transplant programs must discontinue the use of donor age acceptance criteria (e.g., 98-99 years) or other screening parameters intended to functionally inactivate candidates.
  • Programs must use established inactive status procedures when a candidate is temporarily unable to accept organ offers.
  • Listing parameters must reflect clinically appropriate ranges and must not be used to prevent organ offers.

OPTN Monitoring Going Forward

The OPTN will regularly review waitlist parameter data to identify potentially ineffective listing practices. The OPTN may contact programs it identifies as having extreme or implausible acceptance ranges and ask them to review and, if necessary, correct those listings.

The OPTN reserves the right to issue further guidance or formal policies based on its review of waitlist parameter data.

The OPTN appreciates your prompt attention to this matter and your continued commitment to maintaining a safe, fair, and reliable organ donation, procurement, and transplantation system.

View the Full Announcement

Discontinuation of COVID-Era Practice Regarding Waitlist Screening Parameters

Apr 6, 2026, 14:55 PM by Anna Shults

From the Organ Procurement and Transplantation Network (OPTN), April 3, 2026

The Organ Procurement and Transplantation Network (OPTN), in collaboration with the Health Resources and Services Administration (HRSA), is notifying members that prior COVID-era guidance permitting the use of certain waitlist screening parameters to prevent organ offers is rescinded, effective immediately.

In April 2020, during the COVID-19 emergency, the OPTN issued guidance permitting transplant programs to temporarily implement waitlist screening criteria. This approach enabled candidates to keep accumulating waiting time even if they were not eligible to receive organ offers at that moment. These criteria included setting donor age limits to a minimum of 98 years and a maximum of 99 years.

The COVID-19 public health emergency has ended. Moving forward, transplant programs must return to using the OPTN-approved procedures to temporarily inactivate candidates. This is critical to ensure patient safety and system integrity. It is inappropriate to continue to use excessively narrow donor acceptance criteria or other screening parameters to effectively render a candidate ineligible for organ offers.

Required Member Actions

  • Transplant programs must discontinue the use of donor age acceptance criteria (e.g., 98-99 years) or other screening parameters intended to functionally inactivate candidates.
  • Programs must use established inactive status procedures when a candidate is temporarily unable to accept organ offers.
  • Listing parameters must reflect clinically appropriate ranges and must not be used to prevent organ offers.

OPTN Monitoring Going Forward

The OPTN will regularly review waitlist parameter data to identify potentially ineffective listing practices. The OPTN may contact programs it identifies as having extreme or implausible acceptance ranges and ask them to review and, if necessary, correct those listings.

The OPTN reserves the right to issue further guidance or formal policies based on its review of waitlist parameter data.

The OPTN appreciates your prompt attention to this matter and your continued commitment to maintaining a safe, fair, and reliable organ donation, procurement, and transplantation system.

View the Full Announcement

Cards

edublock
Card - Card Template

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore

Call To Action
edublock
Card - Cardstyle 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore

Card - Text Over BG

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore

Call To Action

Card Hero

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore

Call To Action

Lists

Note Simple List And Arrow List are also available as styles
Simple List

2022 Redesign

  • Lorem ipsum dolor
  • Duis aute irure dolor
  • Excepteur sint occaecat
  • Sed ut perspiciatis
Arrow List
  • Lorem ipsum dolor
  • Duis aute irure dolor
  • Excepteur sint occaecat
  • Sed ut perspiciatis
Expandable List

2022 Redesign

Documents

Title Type Size
ASTS signs on to Lorna Breen Act Appropriations Request for FY2027 - March 27, 2026 pdf 118 KB DownloadASTS signs on to Lorna Breen Act Appropriations Request for FY2027 - March 27, 2026
TTC_FDA Meeting Request_12.17.25-1 pdf 227 KB DownloadTTC_FDA Meeting Request_12.17.25-1
ASTS Factsheet_LDPA_October 2025 pdf 161 KB DownloadASTS Factsheet_LDPA_October 2025
Implementing Innovations in Perfusion Technology Workshop Prospectus pdf 327 KB DownloadImplementing Innovations in Perfusion Technology Workshop Prospectus
ASTS Comments on the 2026 Proposed OPO Conditions of Coverage - March 31, 2026 pdf 1674 KB DownloadASTS Comments on the 2026 Proposed OPO Conditions of Coverage - March 31, 2026
final_2026 ASTS Annual Prospectus pdf 8416 KB Downloadfinal_2026 ASTS Annual Prospectus
SORT Program Agenda pdf 830 KB DownloadSORT Program Agenda
ASTS Advocacy Philosophy pdf 218 KB DownloadASTS Advocacy Philosophy
ASTS thanks Senate HELP Committee for advancing LDPA - February 27, 2026 pdf 194 KB DownloadASTS thanks Senate HELP Committee for advancing LDPA - February 27, 2026
ASTS joins group letter in support of FY27 appropriations for kidney health and transplant - March 6, 2026 pdf 85 KB DownloadASTS joins group letter in support of FY27 appropriations for kidney health and transplant - March 6, 2026
A-NRP Training Standards_January 2026 APPROVED pdf 245 KB DownloadA-NRP Training Standards_January 2026 APPROVED
2026 Advocacy Day Prospectus pdf 3177 KB Download2026 Advocacy Day Prospectus
Instructions for uploading surgical logs in TAC Portal - After Fellowship pdf 372 KB DownloadInstructions for uploading surgical logs in TAC Portal - After Fellowship
jamasurgery_markmann_2022_oi_210103_1646152865.19267-2 pdf 750 KB Downloadjamasurgery_markmann_2022_oi_210103_1646152865.19267-2
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion pdf 435 KB DownloadGeographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion
Wall (2023) - Six-month abdominal transplant recipient outcomes from donation after circulatory death heart donors, a retrospect pdf 1256 KB DownloadWall (2023) - Six-month abdominal transplant recipient outcomes from donation after circulatory death heart donors, a retrospect
Brubaker (2024) - US Liver Transplant Outcomes After Normothermic Regional Perfusion vs Standard Super Recovery pdf 424 KB DownloadBrubaker (2024) - US Liver Transplant Outcomes After Normothermic Regional Perfusion vs Standard Super Recovery
ASTS Comments - PY2 IOTA Model - February 9, 2026 pdf 1999 KB DownloadASTS Comments - PY2 IOTA Model - February 9, 2026
ASTS Response - HRSA Directive for OPTN Donation after Circulatory Death Policy Development - January 16, 2026 pdf 152 KB DownloadASTS Response - HRSA Directive for OPTN Donation after Circulatory Death Policy Development - January 16, 2026
ASTS Response - Directive to Reduce the Risk of Donor Derived Rabies Transmission - January 16, 2026 pdf 163 KB DownloadASTS Response - Directive to Reduce the Risk of Donor Derived Rabies Transmission - January 16, 2026